Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StimCell Energetics Inc. is developing proprietary device-based technology aimed at improving cellular energetics to promote wellness and address chronic conditions such as diabetes, hypertension, neuropathy, kidney dysfunction, and aging-related decline. The main product line is based on the eBalance® platform. As of late 2024/early 2025, clinical results are not detailed in public sources; development has been hampered by financial constraints leading to temporary suspension of some R&D activities until further funding is secured.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StimCell Energetics.